- Home
- RGC vs GRX Comparison
RGC vs GRX Comparison
Compare RGC & GRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RGC | GRX |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.8B | 147.2M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | RGC | GRX |
|---|---|---|
| Price | $21.00 | $9.65 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 298.0K | 39.7K |
| Earning Date | 10-24-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.98% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $38.50 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.09 | $7.73 |
| 52 Week High | $83.60 | $10.40 |
Technical Indicators
Market Signals| Indicator | RGC | GRX |
|---|---|---|
| Relative Strength Index (RSI) | 61.10 | 56.69 |
| Support Level | $16.30 | $9.62 |
| Resistance Level | $26.42 | $9.73 |
| Average True Range (ATR) | 2.04 | 0.15 |
| MACD | 0.75 | 0.01 |
| Stochastic Oscillator | 49.32 | 66.67 |
Price Performance
Historical ComparisonAbout RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
About GRX The Gabelli Healthcare & Wellness Trust of Beneficial Interest
Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.